AGA Supports Fecal Microbiota-Based Therapies for C Diff in New Guideline

The guideline recommends fecal microbiota transplant in most cases of recurrent Clostridioides difficile infection but does not suggest fecal microbiota-based therapies for IBD or IBS.

Related Keywords

United States ,American ,Amanda Kabage ,Anne Peery ,University Of North Carolina School Medicine ,American Gastroenterological Association ,School Of Medicine Anne Peery ,North Carolina School ,Cochrane Central Register ,Controlled Trials ,Cochrane Database ,Systematic Reviews ,Ibd ,Inflammatory Bowel Disease ,Ribs ,Irritable Bowel Syndrome ,C Diff ,Clostridioides Difficile ,Infection ,Cfmt ,Fecal Microbiota Transplant ,